CD34 and colorectal carcinoma: Then, to determine whether Vox directly acted on hematopoietic stem and progenitor cells, we designed a quantitative flow cytometry panel that allows identifying mature (Gr-1hiCD11b+) and immature (Gr-1hiCD11blow/neg) neutrophils, granulocyte/monocyte precursors (GMP) (LinnegCD11bnegcKit+SCA1negCD16/32+CD34+) and hematopoietic stem cells (LSK cells) (LinnegCD11bnegcKit+SCA1+) in bone marrow samples from mice harboring CRC-PM and treated with the different drugs (online supplemental figure 3B).